Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. (OTC:CURLF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for CURLF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-08, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for CURLF spans 425, 8-K, F-80, 10-Q.

Recent high-impact activity:

• Curaleaf Fact Sheet Escalates Hostile Bid: Accuses Aurora of Dilutive ATM Sales Below Offer Value (2026-09-08)
• Curaleaf Escalates Hostile Bid: Reveals Aurora Sold Shares at US$3.09–$3.57, Far Below Its Own Rejection Price (2026-09-02)
• Curaleaf Counters Aurora's Circular with Details on $398M Dilution and Cash Burn (2026-09-02)
• Curaleaf Escalates Hostile Bid War, Rebuts Aurora's Engagement Claims (2026-08-24)
• Curaleaf Registers 24M Shares for Hostile Aurora Takeover Bid (2026-08-18)

Insider Transactions

CURLF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.